Table 1 Demographic and anthropometric data of the studied population of IBD
Age, Mean (SD), years | 39.28 (11.42) |
|---|---|
Sex, N (%) | |
Male | 44 (45.8) |
Female | 52 (54.2) |
Type of IBD, N (%) | |
UC | 76 (79.2) |
CD | 18 (18.8) |
Undifferentiated | 2 (2.1) |
Duration of the bowel disease, Median (SE) | 5 (0.65) |
Body Mass Index (BMI), Mean (SD), kg/m2 | 26.26 (4.36) |
BMI group, N (%) | |
Underweight (< 18.5) | 1 (1) |
Normal (18.5–24.9) | 52 (54.2) |
Overweight (25–29) | 27 (28.1) |
Obese (≥30) | 16 (16.7) |
Waist circumference, Mean (SD), cm | 89.35 (10.40) |
Abdominal circumference, Mean (SD), cm | 97.4 (10.97) |
Medication, N (%) | |
Sulfunamides (Asacol, Mesalazine, Sulfasalazine) | 78 (81.2) |
Anti-TNF (Remicade, Cinnora) | 18 (18.8) |
Azathioprine | 39 (40.6) |
Prednisolone | 37 (38.5) |